TAS-205 showed no significant impact on motor function in patients with Duchenne muscular dystrophy (DMD), highlighting the ongoing search for effective treatments for the rare condition.

Vor Bio is licensing global rights to a fusion protein that inhibits two targets to potentially treat the neuromuscular disorder generalized myasthenia gravis. It’s a pivot for Vor, which last ...

The drought monitor shows severe-to-extreme drought conditions across New Mexico but some heavy rainfall may help – maybe too well.

The Company also announced the first patient has been dosed in the global Phase 2 NEULARK clinical trial of NEU-411, a brain-penetrant, potent and selective inhibitor of LRRK2, in people with ...

Microsoft co-founder Bill Gates reflects on his father's Alzheimer's battle and expresses optimism about advancements in early diagnosis for the disease affecting millions.

Highly charged muonic ions observed in gas-phase experiment for first time by Kavli Institute for the Physics and Mathematics of the Universe ...

U.S. solar stocks tumbled on Tuesday after a Senate panel proposed phasing out solar and wind tax credits by 2028, as part of changes to President Donald Trump's sweeping tax-and-spending bill.

Bristol Myers Squibb presents late-breaking data from pivotal phase 3 POETYK PsA-1 trial demonstrating superiority of Sotyktu (deucravacitinib) compared with placebo in adults with psoriatic ...

Samir Helio Pazzoto-Filho, charged with attempted murder in a Highway 26 crash, removed his GPS monitor and vanished after posting bail, court records show.

In a prespecified analysis of a phase 3 trial, sibeprenlimab halved proteinuria in adults with IgA nephropathy.

The Arzopa Z1FC is billed as a “portable gaming monitor,” but it’s actually a solid choice for anyone who needs an affordable portable display.

Moonlake is running phase 3 studies of the nanobody in psoriatic arthritis and advancing the drug candidate toward pivotal trials in psoriasis, palmoplantar pustulosis and axial spondyloarthritis.